Search Within

Mark Weiss

  1. "Lymphoma"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (4)
Groups
  1. Center for Hematologic Malignancies (9)
  2. Department of Medicine (9)
  3. Hematologic Malignancies, Division of (9)
  4. Lymphoma (9)
  5. Adult Leukemia (6)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)

More Groups

People
  1. Andrew Zelenetz (8)
  2. Peter Maslak (6)
  3. Ariela Noy (5)
  4. David Scheinberg (4)
  5. David Golde (3)
  6. Nicole Lamanna (3)

More People

Years
  1. 2009 (1)
  2. 2008 (1)
  3. 2006 (1)
  4. 2005 (1)
  5. 2001 (1)
  6. 2000 (1)

More Years

Publications
  1. Blood (4)
  2. Journal of Clinical Oncology (2)
  3. Annals of Oncology (1)
  4. General Hospital Psychiatry (1)
  5. Leukemia (1)
Publishers
  1. American Society of Hematology (4)
  2. American Society of Clinical Oncology (2)
  3. Elsevier Science, Inc. (1)
  4. Nature Publishing Group (1)
  5. Oxford University Press (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
    Journal Article

    Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Life-threatening serotonin toxicity due to a citalopram-fluconazole drug interaction: case reports and discussion
    Journal Article

    Levin, T. T.; Cortes-Ladino, A.; Weiss, M.; Palomba, M. L.
    General Hospital Psychiatry (2008)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia
    Journal Article

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J. G.; Heaney, M.; Brentjens, R.; Zelenetz, A. D.; Horgan, D.; Gencarelli, A.; Panageas, K. S.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Combination chemotherapy regimens with pentostatin in patients with chronic lymphocytic leukemia and other low grade lymphoid neoplasms
    Meeting Abstract

    Weiss, M. A.; Kalaycio, M.; Zelenetz, A. D.; Lamanna, N.
    Annals of Oncology (2005)

    Fulltext@MSK | Save
  • Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: Results from a sequential treatment CLL protocol
    Journal Article

    Noy, A.; Verma, R.; Glenn, M.; Maslak, P.; Rahman, Z. U.; Keenan, J. R.; Weiss, M.; Filippa, D.; Zelenetz, A. D.
    Blood (2001)

    Fulltext@MSK | Save
  • Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy
    Journal Article

    Weiss, M. A.; Glenn, M.; Maslak, P.; Rahman, Z.; Noy, A.; Zelenetz, A.; Scheinberg, D. A.; Golde, D. W.
    Leukemia (2000)

    Fulltext@MSK | Save
  • Consolidation therapy with high-dose cyclophosphamide (HDC) reduces minimal residual disease in patients with chronic lymphocytic leukemia (CLL) treated with fludarabine as induction therapy
    Meeting Abstract

    Weiss, M.; Glenn, M.; Maslak, P.; Rahman, Z.; Megherian, L.; Noy, A.; Zelenetz, A.; Scheinberg, D.; Golde, D.
    Blood (1996)

    Fulltext@MSK | Save
  • Clonotypic PCR confirms minimal residual disease (MRD) in CLL nodular PR: Preliminary results from a sequential treatment CLL protocol
    Meeting Abstract

    Noy, A.; Verma, R.; Rahman, Z. U.; Glenn, M.; Maslak, P.; Weiss, M.; Zelenetz, A. D.
    Blood (1996)

    Fulltext@MSK | Save
  • Effective immunological purging of bone marrow contaminated by a malignant B cell clone as assessed by RNAse protection assay
    Meeting Abstract

    Rahman, Z.; Verma, R.; White, K.; Weiss, M.; Zelenetz, A. D.; Gabrilove, J.
    Blood (1993)

    Fulltext@MSK | Save